AbbVie, Allergan deal approved in Taiwan
MLex Summary: The proposed $63 billion acquisition of Dublin-based pharmaceutical company Allergan by Chicago-based AbbVie has been approved by the Taiwan Fair Trade Commission today, the regulator said in a statement....To view the full article, register now.
Already a subscriber? Click here to view full article